Paper Details

  1. Home
  2. Paper Details

Afatinib Therapy: Practical Management of Adverse Events With an Oral Agent for Non-Small Cell Lung Cancer Treatment.

Author: AndanChristine, EdwardsRebecca L, LacoutureMario E, LallaRajesh V, O'BrienDennis, SequistLecia V

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Afatinib, an oral EGFR inhibitor, is approved for first-line treatment of certain lung cancers with specific EGFR mutations and for metastatic squamous non-small cell lung cancer after platinum-based chemotherapy. Common side effects include gastrointestinal and skin problems.
Paper Details　
Original Abstract of the Article :
Afatinib is an oral, irreversible ErbB family blocker indicated for first-line treatment of metastatic non-small cell lung cancer (NSCLC) in patients with non-resistant epidermal growth factor receptor (EGFR) mutations. Afatinib is also approved for the treatment of metastatic squamous NSCLC followi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/30239509

データ提供：米国国立医学図書館（NLM）

Afatinib Therapy: Practical Management of Adverse Events in NSCLC

This study navigates the complex terrain of [non-small cell lung cancer] (NSCLC) treatment, focusing on the management of adverse events associated with the [oral] medication [afatinib]. This research provides valuable insights into the practical aspects of [afatinib] therapy, specifically addressing the challenges of [gastrointestinal] and [dermatologic] toxicities. The study highlights the crucial role of [dose adjustments] and [supportive care] in optimizing patient outcomes while minimizing the adverse effects of [afatinib] therapy.

Balancing the Benefits and Risks of Afatinib

This research underscores the importance of careful monitoring and management of [afatinib]-associated adverse events, as they can significantly impact patient quality of life and treatment adherence. These findings provide practical guidance for healthcare professionals managing patients on [afatinib] therapy, emphasizing the need for a comprehensive approach that considers both the therapeutic benefits and the potential risks of this treatment.

Navigating the Side Effects of Lung Cancer Treatment

Understanding the potential side effects of [afatinib] is crucial for patients and their caregivers. This research serves as a valuable resource for navigating these challenges, providing practical advice on managing adverse events. By working closely with healthcare professionals, patients can effectively mitigate potential side effects and optimize their treatment experience.

Dr.Camel's Conclusion

Just as a camel adapts to the harsh desert conditions, patients undergoing [afatinib] therapy must navigate the potential side effects. This study sheds light on the challenges and strategies involved in managing [afatinib]-associated toxicities. It's like a well-equipped camel caravan, prepared for the desert journey with essential supplies (supportive care) and a skilled guide (healthcare professional) to ensure a smooth and successful voyage through the treatment process.
Date :
  1. Date Completed 2019-08-05
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

30239509

DOI: Digital Object Identifier

NIHMS1783602

Related Literature

Article Analysis
・Side Effects of afatinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.